Radiotherapy & Oncology
- ISSN: 0167-8140
Editor-In-Chief: Baumann
Next planned ship date: March 21, 2024
- 5 Year impact factor: 5.8
- Impact factor: 5.7
Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation OncologyESTRO members can access Radiotherapy and Oncology on… Read more
Subscription options
Next planned ship date:
March 21, 2024
Institutional subscription on ScienceDirect
Request a sales quoteJournal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology
ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.
Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
Editorial Office:
Professor Michael Baumann, Editor-in-Chief, Radiotherapy and Oncology Editorial Office, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany (email: [email protected]).
ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.
Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
Editorial Office:
Professor Michael Baumann, Editor-in-Chief, Radiotherapy and Oncology Editorial Office, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany (email: [email protected]).
- ISSN: 0167-8140
- Volume 12
- Issue 12
- 5 Year impact factor: 5.8
- Impact factor: 5.7
Read the Radiotherapy & Oncology Guide for Authors, Open Access policy, and latest articles on ScienceDirect